Tumor Biology

, Volume 36, Issue 11, pp 8341–8348 | Cite as

Prognostic value of age in neurological cancer: an analysis of 22,393 cases from the SEER database

  • Minjie Tian
  • Donglin Zhu
  • Daowen Chen
  • Xiaoli Huo
  • Jianqing Ge
  • Jie Lu
  • Li Zhang
  • Jingping Shi
Research Article


Although the risk of neurological cancer (NC) is age-dependent, few studies have evaluated the prognostic value of age in determining NC survival in a large population. The aim of this retrospective study was to compare the long-term survival of young and elderly NC patients. We searched the Surveillance, Epidemiology, and End-Results database and identified 22,393 patients who were diagnosed with NC between 1988 and 2003 and were treated with surgery. Patients were categorized as young (≤40 years old) or elderly (>40 years old), and 5-year NC-specific survival (NCSS) data were obtained for each patient. A Kaplan-Meier survival analysis and the Cox proportional hazards model were used to analyze long-term survival outcomes and risk factors. The two groups differed significantly in terms of pathological grade, histological type, stage, and tumor size (P < 0.001). A difference in 5-year NCSS rates (63.8 and 19.0 % in young and elderly patients, respectively) was detected by uni- and multivariate analyses. A stratified analysis of age on cancer survival revealed significant differences at T1–T4 stages. Age has prognostic value for determining NC risk. NCSS is higher in young than in elderly NC patients.


Age Brain cancer SEER 


Conflicts of interest


Authors’ contributions

MT and JS designed the study. DZ, DC and XH provided the databases. MT, DZ, JG, JL, and JS assembled and analyzed the data. MT, DC, and LZ wrote the manuscript. All authors read and approved the final manuscript.


  1. 1.
    Gabriel A, Batey J, Capogreco J, Kimball D, Walters A, Tubbs RS, et al. Adult brain cancer in the U.S. Black population: a surveillance, epidemiology, and end results (seer) analysis of incidence, survival, and trends. Med Sci Monit. 2014;20:1510–7.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Tsao-Wei DD, Hu J, Groshen SG, Chamberlain MC. Conditional survival of high-grade glioma in Los Angeles county during the year 1990–2000. J Neurooncol. 2012;110:145–52.CrossRefPubMedGoogle Scholar
  3. 3.
    Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25:867–90.CrossRefPubMedGoogle Scholar
  4. 4.
    Johannesen TB, Angell-Andersen E, Tretli S, Langmark F, Lote K. Trends in incidence of brain and central nervous system tumors in Norway, 1970–1999. Neuroepidemiology. 2004;23:101–9.CrossRefPubMedGoogle Scholar
  5. 5.
    McKinley BP, Michalek AM, Fenstermaker RA, Plunkett RJ. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J Neurosurg. 2000;93:932–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Modan B, Wagener DK, Feldman JJ, Rosenberg HM, Feinleib M. Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol. 1992;135:1349–57.CrossRefPubMedGoogle Scholar
  7. 7.
    Khurana VG, Teo C, Kundi M, Hardell L, Carlberg M. Cell phones and brain tumors: a review including the long-term epidemiologic data. Surg Neurol. 2009;72:205–14. discussion 214–205.CrossRefPubMedGoogle Scholar
  8. 8.
    Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, et al. Cellular-telephone use and brain tumors. N Engl J Med. 2001;344:79–86.CrossRefPubMedGoogle Scholar
  9. 9.
    Volkow ND, Tomasi D, Wang GJ, Vaska P, Fowler JS, Telang F, et al. Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA. 2011;305:808–13.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology. 2002;4:278–99.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Li Q, Cai G, Li D, Wang Y, Zhuo C, Cai S. Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69,835 patients in SEER database. PLoS ONE. 2014;9:e93756.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Porter KR, McCarthy BJ, Berbaum ML, Davis FG. Conditional survival of all primary brain tumor patients by age, behavior, and histology. Neuroepidemiology. 2011;36:230–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zhang W, Sun B. Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the seer database. Oncotarget. 2015;6:633–41.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Zhang W, Jiang R, Hou J, Sun B. Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer. Medicine (Baltimore). 2015;94:e684.CrossRefGoogle Scholar
  15. 15.
    Fang Z, Kulldorff M, Gregorio DI. Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis. Neuro-Oncology. 2004;6:179–87.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG. Trends in incidence of primary brain tumors in the United States, 1985–1994. Neuro-Oncology. 2001;3:141–51.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J Neurosurg. 1998;88:1–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Korshunov A, Sycheva R, Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years. Cancer. 2005;104:825–32.CrossRefPubMedGoogle Scholar
  19. 19.
    Walid MS. Prognostic factors for long-term survival after glioblastoma. Perm J. 2008;12:45–8.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Chew MH, Koh PK, Ng KH, Eu KW. Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution. Int J Color Dis. 2009;24:1075–83.CrossRefGoogle Scholar
  21. 21.
    Serra-Rexach JA, Jimenez AB, Garcia-Alhambra MA, Pla R, Vidan M, Rodriguez P, et al. Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist. 2012;17:1277–85.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Rose JH, O’Toole EE, Dawson NV, Thomas C, Connors Jr AF, Wenger NS, et al. Age differences in care practices and outcomes for hospitalized patients with cancer. J Am Geriatr Soc. 2000;48:S25–32.CrossRefPubMedGoogle Scholar
  23. 23.
    Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–55. discussion 155–146.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Chang SM, Barker 2nd FG. Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer. 2005;104:1975–84.CrossRefPubMedGoogle Scholar
  25. 25.
    Curry Jr WT, Barker 2nd FG. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009;93:25–39.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Minjie Tian
    • 1
  • Donglin Zhu
    • 1
  • Daowen Chen
    • 1
  • Xiaoli Huo
    • 1
  • Jianqing Ge
    • 1
  • Jie Lu
    • 1
  • Li Zhang
    • 1
  • Jingping Shi
    • 1
  1. 1.Department of Neurology, Nanjing Brain HospitalNanjing Medical UniversityNanjingChina

Personalised recommendations